Potential target therapy in meningiomas: role of Dkk-3 and claudin-5
EANS Academy. Caffo M. 09/27/19; 276091; EP04029
Maria Caffo
Maria Caffo

Access to this content is reserved for EANS members and attendees of this event. Click here to become an EANS member and gain your access to the full content of the EANS Academy

Discussion Forum (0)
Rate & Comment (0)
Meningiomas are the most common tumors of the CNS. The histological grading is the most impor­tant prognostic factor. The Dkk-3 protein is involved in embryonic develop­ment through its interactions with the Wnt pathway. Over-expression of Dkk-3 cause reduced cell proliferation and invasion. The REIC/Dkk-3 expression has been shown to be down-regulated in various cancer cell lines. Claudin-5 is a membrane protein which plays a role in the regulation of tumor cell motility. The aim of this study is to demonstrate the role of the Dkk-3 and claudin-5 in meningiomas of different histotype.
We evaluated Dkk-3 and claudin-5 expression in 30 tumors biopsies assessing both immunohistochemistry and western blotting. The expression strength was analyzed and graded based on the positive ratio and intensity of immunoreactivity. The molec­ular analyses were performed on frozen sections of tumor tissue, by West­ern Blot method. Statistical analysis was also performed.
The expression of Dkk-3 protein and claudin-5 were decreased in meningioma samples compared to controls. Also immunohistochemistry shows a slight expression of Dkk-3 pro­tein in meningioma samples examined. Claudin-5 levels were inversely expressed in meningiomas with reduced levels compared to controls.
Our results show that Dkk-3 and claudin-5 are down-regulated. More, we demonstrated an alteration of the BBB and a decreasing of apoptotic susceptibility. The immunoreactivity of vascular neoplastic endothelium suggest a role in angiogenesis. These data could suggest a key role of Dkk-3 in the progression of meningiomas through its onco-suppressor potential. At the same time, the demonstration of the altered expression of claudin-5 confirms its protective role in modulating the integrity of the barrier, in response to an abnormal condition of neuronal cells due to the onset of the tumor. We suggest that the re-establishment of Dkk-3 expression can represent a new potential therapeutic approach in meningiomas treat­ment also by modulation of BBB permeability.
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings